Search Results - "Bassendine, M.F"

Hepatitis C virus and atherosclerosis: A legacy after virologic cure? by Bassendine, M.F, Nielsen, S.U, Bridge, S.H, Felmlee, D.J, Sheridan, D.A, Packard, C.J, Neely, R.D

“…Summary Hepatitis C virus (HCV) is a major pathogen with approximately 3% of the world's population (over 170 million) infected. Epidemiological studies have…”
Get full text

903 OMEGA-3 FATTY ACIDS AND/OR FLUVASTATIN IN HEPATITIS C PRIOR NON-RESPONDERS TO COMBINATION ANTI-VIRAL THERAPY – A PILOT RANDOMISED CLINICAL TRIAL by Sheridan, D.A, Bridge, S.H, Crossey, M.M.E, Felmlee, D.J, Fenwick, F, Thomas, H.C, Neely, D, Taylor-Robinson, S.D, Bassendine, M.F

Get full text

493 METABOLIC SYNDROME AND INSULIN RESISTANCE ARE ASSOCIATED WITH MAXIMUM HEPATITIS C LIPOVIRAL PARTICLES IN GENOTYPE 1 INFECTION by Sheridan, D.A, Felmlee, D.J, Bridge, S.H, Fenwick, F, Askew, B, Neely, D, Crossey, M.M.E, Taylor-Robinson, S.D, Toms, G.L, Bassendine, M.F

Get full text

1079 INSULIN RESISTANCE CORRELATES WITH LOW DENSITY HEPATITIS C VIRUS PARTICLES IN GENOTYPE 1 INFECTION by Bridge, S.H, Sheridan, D.A, Felmlee, D.J, Nielsen, S.U, Neely, R.D.G, Toms, G.L, Bassendine, M.F

Get full text

856 ANALYSIS OF REACTIVITY OF PBC SERA WITH BACTERIAL ANTIGENS MODIFIED BY XENOBIOTIC EXPOSURE by Welsh, S, Nielsen, S.U, Ward, A.C, Bassendine, M.F

Get full text

Low density Hepatitis C virus particles (lipoviral particles) associate with insulin resistance in genotype 1 infection by Bridge, S.H, Sheridan, D.A, Felmlee, D.J, Toms, G.L, Neely, R.D.G, Bassendine, M.F

Get full text

Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus by van der Laan, L.J.W, Hudson, M, McPherson, S, Zondervan, P.E, Thomas, R.C, Kwekkeboom, J, Lindsay, A.S, Burt, A.D, Kazemier, G, Tilanus, H.W, Bassendine, M.F, Metselaar, H.J

“…Abstract A 2-center retrospective analysis was performed in 60 patients undergoing liver transplantation for hepatitis C virus (HCV)–related disease…”
Get full text

1078 HYPOCHOLESTEROLAEMIA IN CHRONIC HEPATITIS C GENOTYPE 3 INFECTION IS DUE TO BOTH REDUCED CHOLESTEROL PRODUCTION AND INCREASED LDL CLEARANCE by Sheridan, D, Bartlett, K, Felmlee, D, Bridge, S.H, Toms, G.L, Dubuc, G, Nabil, S, Davignon, J, Neely, D, Bassendine, M.F

Get full text

Hypocholesterolaemia in chronic Hepatitis C virus (HCV) infection – Reduced production or increased LDL clearance? by Sheridan, D.A, Bartlett, K, Felmlee, D.J, Bridge, S.H, Toms, G.L, Dubuc, G, Seidah, N.G, Davignon, J, Neely, R.D.G, Bassendine, M.F

Get full text

Tamoxifen: a novel treatment for primary biliary cirrhosis? by Reddy, A., Prince, M., James, O.F., Jain, S., Bassendine, M.F.

“…: Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease, which predominantly affects women. It is characterised histologically by…”
Get full text

Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody by Pumeechockchai, W., Bevitt, D., Agarwal, K., Petropoulou, T., Langer, B.C.A., Belohradsky, B., Bassendine, M.F., Toms, G.L.

“…The purpose of this study was to analyse the influence of the humoral immune response on the generation and clearance of hepatitis C virus (HCV) RNA containing…”
Get full text

P.214 Steatosis in chronic HCV infection: viral and host characteristics by Price, D.A., Burt, A.D., Schmid, M.L., Craig, W.L., Bassendine, M.F.

Get full text

WITHDRAWN: The effect of hepatitis C virus on serum lipids by Neely, D., Price, D.A., Toms, G., Agawal, K., Bassendine, M.F., Schmid, M.L.

Get full text

P.488 Chronic hepatitis C in injecting drug users: a comparison with non-injecting drug users in the same geographic area by Price, D.A., Schmid, M.L., Agarwal, K., Hewett, M., Craig, W.L., Burt, A.D., Bassendine, M.F.

Get full text

P.288 Microsomal triglyceride transfer protein gene promoter polymorphism (493g allele) is associated with severity of hcv-associated steatosis by Price, D.A., Donaldson, P.T., Ann, D.K., Leathart, J.B., Burt, A.D., Schmid, M.L., Bassendine, M.F.

Get full text

Host and viral characteristics associated with steatosis in chronic hepatitis C by Price, D.A, Burt, A.D, Turner, A, Craig, W.L, Schmid, M.L, Bassendine, M.F

Get full text

A population based study of autoimmunity in primary biliary cirrhosis (PBC) patients and their families: evidence for a shared susceptibility by Watt, F.E., Bassendine, M.F., James, O.F.W., Jones, D.E.J.

Get full text

Managing chronic hepatitis C acquired through intravenous drug use by Jowett, S.L., Agarwal, K., Smith, B.C., Craig, W., Hewett, M., Bassendine, D.R., Gilvarry, E., Burt, A.D., Bassendine, M.F.

“…We retrospectively reviewed the provision and uptake of hospital services for 253 current and ex‐intravenous drug users with hepatitis C virus (HCV). Overall,…”
Get full text

A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results by Mitchison, H C, Palmer, J M, Bassendine, M F, Watson, A J, Record, C O, James, O F

“…The results of a 3-year, placebo-controlled trial of prednisolone treatment in primary biliary cirrhosis (PBC) are presented. The active (n = 19) and placebo…”
Get more information

Genetic susceptibility to primary biliary cirrhosis (PBC): analysis of chemokine receptor 5 (CCR5) delta32 deletion by Baragiotta, A.M., Floreani, A., Jones, D., Venturi, C., Agarwal, K., James, O.F.W., Donaldson, P.T.D., Bassendine, M.F.

Get full text